Edwards Lifesciences Securities Settlement: Who Can File a Claim

Investors who acquired Edwards Lifesciences common stock from February 6 through July 24, 2024 and suffered qualifying losses may share in this proposed $39 million settlement. Payments depend on recognized losses and approved claims; shares sold before the July 24 market close have no recognized loss. Claims with trading records are due December 2, 2026.

Edwards Lifesciences Securities Settlement
Proof Needed Featured

Claims open Deadline: December 2, 2026

Who qualifies?

Investors who acquired Edwards Lifesciences common stock from February 6 through July 24, 2024, and suffered damages may qualify. Shares sold before the close of trading on July 24 have no recognized loss under the payment formula.

How much could I receive?

The estimated average is $0.66 per eligible share before fees and other deductions. Your actual payment depends on your trades, calculated losses and other valid claims. Calculated payments below $10 will not be distributed.

Do I need supporting documents?

Yes. Submit brokerage statements, confirmations or authorized broker records documenting holdings and trades. The claim also requests the last four digits of your Social Security or taxpayer identification number. Keep your records; the administrator does not already have your transaction history.

Do I need a notice ID or PIN?

The available materials do not establish whether a notice ID or PIN is required. If you did not receive a form or need filing help, contact the administrator at 833-930-0555.

What is the deadline?

Submit your claim online by December 2, 2026, or mail it postmarked by that date. A timely claim with supporting documentation is required to receive a share of the settlement.

How do I claim?

Complete the official claim online or by mail and attach your trading records. File separately for each legal entity or separately managed account; all joint owners must sign. Do not include shares held through an Edwards ERISA employee benefit plan.

Open the official settlement website →

What is the estimated recovery per share?

The notice gives an overall estimate before court-approved deductions. A person’s payment depends on the allocation formula, documented transactions, recognized loss, and the total value of valid claims.

  • The notice estimates an average recovery of about $0.66 per eligible share before court-approved fees, expenses, taxes, and administration costs.
  • This is only an overall estimate, not a promised payment. Your amount can be higher or lower based on your trading history and the total value of valid claims.

Can I claim shares held through an Edwards ERISA retirement or benefit plan?

Do not list shares held through an ERISA-covered Edwards employee benefit plan on this claim.

  • Shares held through an Edwards employee benefit plan covered by ERISA should not be included on your claim form.
  • You may include only Edwards shares you bought or acquired outside that ERISA plan.

What if I traded options or acquired common stock by exercising an option?

The settlement covers Edwards common stock, not option contracts.

  • Options themselves are not eligible for a payment.
  • If you bought or sold Edwards common stock by exercising an option, the stock transaction may be considered. The relevant date is the option exercise date, and the price is the exercise price.

Which transactions receive no recognized loss under the proposed plan?

The proposed plan does not treat every Class Period transaction as producing a recognized loss.

  • A share sold before the close of trading on July 24, 2024 has a recognized loss amount of $0 under the proposed allocation plan.
  • Short sales and purchases used to cover short sales also have a recognized loss amount of $0.

How are multiple purchases and sales matched when my claim is calculated?

This matching method can affect how the administrator calculates a claim.

  • All purchases and sales from February 6, 2024 through October 22, 2024 are matched using “last in, first out” (LIFO).
  • That means sales are first matched to the most recent earlier purchases, working backward, before any shares owned at the start of the Class Period are used.

What records should I keep for my claim?

The specific documentation standards are not provided in this notice.

  • The notice requires adequate supporting documentation but does not list the exact documents required for a payment claim.
  • Keep all records showing your ownership of and transactions in Edwards common stock. The notice says the parties and Claims Administrator do not have your transaction information.

What do I need to do if I want to exclude myself?

Leaving the settlement is also called opting out. It preserves your ability to pursue your own related claim, but it gives up any payment from this settlement.

  • To leave the settlement, mail a written Request for Exclusion so it is received by December 2, 2026.
  • The request must give your contact information, state that you request exclusion in this case, list specified share holdings and Class Period transactions, and be signed.
  • If you exclude yourself, you cannot receive money from this settlement.

Could there be another payment after the first distribution?

A later payment is possible, but it is not guaranteed.

  • If the first payment is made and money remains six months later, the administrator may make another distribution if Lead Counsel and the Claims Administrator decide it is cost-effective.
  • Later distributions go only to authorized claimants who cashed their earlier payment and would receive at least $10 more.

Other Important Dates

  • Exclusion deadline: 2026-12-02
  • Objection deadline: 2026-12-02
  • Final approval hearing: December 16, 2026, at 1:30 p.m. Pacific Time
  • Hearing location: Courtroom 9C, 9th Floor of the Felicitas and Gonzalo Mendez United States Courthouse, 350 W 1st Street, Los Angeles, CA 90012

Case Details

  • Total settlement fund: $39,000,000
  • Case name: Patel v. Edwards Lifesciences Corp.
  • Case number: 8:24-cv-02221-AH-KES
  • Court: United States District Court for the Central District of California
  • Administrator: Kroll Settlement Administration
  • Official Settlement Website: https://www.EdwardsLifesciencesSecuritiesLitigation.com

Sources

Official Settlement Website
Claim form, FAQ, deadlines, administrator information
Visit Site →
Official Settlement Notice (PDF)
Court-approved notice describing eligibility and benefits
Open PDF →
Official NoticeRead the full notice

Official Notice

Read the notice PDF or the text version below.

Information last updated on 2026-10-21